Goldman Sachs Group Inc Vapotherm Inc Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$1.44 - $13.52 $58,276 - $547,154	-40,470 Reduced 73.94%	14,265 $22,000
Q3 2022 Nov 10, 2022	SELL	$1.44 - $13.52 $58,276 - $547,154	-40,470 Reduced 73.94%	14,265 $0
Q2 2022 May 14, 2024	BUY	$2.52 - $14.42 $137,932 - $789,278	54,735 New	54,735 $139,000
Q2 2022 Aug 15, 2022	SELL	$2.52 - $14.42 $88,676 - $507,425	-35,189 Reduced 39.13%	54,735 $139,000
Q1 2022 May 16, 2022	BUY	$12.69 - $20.72 $101,266 - $165,345	7,980 Added 9.74%	89,924 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$19.7 - $23.71 $1.07 Million - $1.29 Million	-54,260 Reduced 39.84%	81,944 $1.7 Million
Q3 2021 Nov 10, 2021	BUY	$21.32 - $29.36 $2.9 Million - $4 Million	136,204 New	136,204 $3.03 Million

1.29M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.